Coultreon Biopharma

Coultreon Biopharma is a clinical-stage biotech company developing precision medicines targeting SIK3 for immunology and autoimmune diseases.

Overview

Coultreon Biopharma's mission is to develop life-changing medicines for patients with chronic inflammatory diseases of high unmet medical need. The company is focused on bringing transformative innovations for autoimmune diseases, with emphasis on oral drugs offering greater efficacy and better safety profiles.

Something wrong or missing? Send an update. Fixed within 24 hours.